Medilab Speciality Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.50 M
as on 16-11-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.95 M
as on 16-11-2024
- Satisfied Charges ₹ 5.69 M
as on 16-11-2024
- Revenue 6.30%
(FY 2023)
- Profit -55.08%
(FY 2023)
- Ebitda 29.70%
(FY 2023)
- Net Worth 1.94%
(FY 2023)
- Total Assets -7.96%
(FY 2023)
About Medilab Speciality Laboratories (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹6.95 M. The company has closed loans amounting to ₹5.69 M, as per Ministry of Corporate Affairs (MCA) records.
Varkey Thathothe and Sarada Varkey serve as directors at the Company.
- CIN/LLPIN
U85195KL2007PTC020318
- Company No.
020318
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medilab Speciality Laboratories (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varkey Thathothe  | Managing Director | 06-Feb-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sarada Varkey | Director | 06-Feb-2007 | Current |
Financial Performance of Medilab Speciality Laboratories (India).
Medilab Speciality Laboratories (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.3% increase. The company also saw a substantial fall in profitability, with a 55.08% decrease in profit. The company's net worth moved up by a moderate rise of 1.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilab Speciality Laboratories (India)?
In 2023, Medilab Speciality Laboratories (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Qindia Consulting Services Private LimitedActive 11 years 8 monthsVarkey Thathothe and Sarada Varkey are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Nov 2023 | ₹0.90 M | Open |
Hdfc Bank Limited Creation Date: 09 Jul 2021 | ₹0.38 M | Open |
Hdfc Bank Limited Creation Date: 30 Mar 2021 | ₹0.65 M | Open |
How Many Employees Work at Medilab Speciality Laboratories (India)?
Medilab Speciality Laboratories (India) has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilab Speciality Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilab Speciality Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
